Skip to main navigation Skip to search Skip to main content

Experience with alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies

  • Stefan Faderl
  • , Deborah A. Thomas
  • , Susan O'Brien
  • , Guillermo Garcia-Manero
  • , Hagop M. Kantarjian
  • , Francis J. Giles
  • , Charles Koller
  • , Alessandra Ferrajoli
  • , Srdan Verstovsek
  • , Barbara Pro
  • , Michael Andreeff
  • , Miloslav Beran
  • , Jorge Cortes
  • , William Wierda
  • , Ngoc Tran
  • , Michael J. Keating

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Experience with alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Keyphrases